Oncimmune Holdings plc (LON:ONC), the leading global immunodiagnostics group, has announced its unaudited results for the year ended 31 May 2020 and provides an update on recent progress. Highlights Commercial
Oncimmune Holdings plc (LON:ONC), the leading global immunodiagnostics group, has noted the initiation of a study by Biodesix Inc using Oncimmune’s EarlyCDT® Lung blood test, which is marketed in the US
Oncimmune Holdings plc (LON:ONC), the leading global immunodiagnostics group, has noted that recently published data from two clinical studies using Oncimmune’s EarlyCDT® Lung blood test, which is marketed in the US by
Oncimmune Holdings plc (LON:ONC), the leading global immunodiagnostics group, will be announcing its full year results for the year ended 31 May 2020 on Friday, 30 October 2020. Adam Hill,
Oncimmune Holdings plc (LON:ONC), the leading global immunodiagnostics group, has announced that, following its announcement on 6 October that Oncimmune is being funded by the UK Government to develop a
Advanced Oncotherapy plc (LON:ONC) goal is to deliver an affordable and novel PT system, called LIGHT, based on state-of-the-art technology developed originally at the world-renowned CERN. Over the past two
The award of funding to Oncimmune Holdings plc (LON:ONC) by the ‘UK Research and Innovation Ideas to Address COVID-19’ project, leverages its proprietary ImmunoINSIGHTS technology to help in predicting disease
Oncimmune Holdings plc (LON:ONC), the leading global immunodiagnostics group, has announced the award of funding from the ‘UK Research and Innovation Ideas to Address COVID-19’ programme, to support a joint collaboration
Oncimmune Holdings plc (LON:ONC), the leading global immunodiagnostics group, has announced that it has signed a collaboration with Genentech, a member of the Roche Group, to characterise the autoantibody profiles
Oncimmune Holdings plc (LON:ONC), the leading global immunodiagnostics group, has noted the publication by PLOS ONE of a study led by Leeds University Academic Unit of Health Economics, supported by
© 2023 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
